Founder of OpenEvidence chatbot says two-thirds of US physicians use the ad-powered tool, prompting a debate about patient care
Excerpt from Financial Times. Original publication ↗
Source: Financial Times
At a glance
- Topic
- Business
- Country
- 🇬🇧 GB
- Publisher language
- EN
- Added to Allnira